Fundies.
English

Segment disclosures

Company overview

Connect Biopharma Holdings Limited

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 15 retained observations 10 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Operating Segments · Treatment Of Respiratory Diseases Segment

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=cntb:TreatmentOfRespiratoryDiseasesSegmentMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-302768000 USD20260812Open filing evidence
2026-01-01 – 2026-06-302937000 USD20260812Open filing evidence
2026-01-01 – 2026-03-31169000 USD20260512Open filing evidence
2025-01-01 – 2025-12-3164000 USD20260331Open filing evidence
2025-07-01 – 2025-09-3016000 USD20251112Open filing evidence
2025-01-01 – 2025-09-3064000 USD20251112Open filing evidence
2025-04-01 – 2025-06-3048000 USD20260812Open filing evidence
2025-01-01 – 2025-06-3048000 USD20260812Open filing evidence
2025-01-01 – 2025-03-310 USD20260512Open filing evidence
2024-01-01 – 2024-12-3126033000 USD20260331Open filing evidence
2024-07-01 – 2024-09-301219000 USD20251112Open filing evidence
2024-01-01 – 2024-09-3025335000 USD20251112Open filing evidence
2024-04-01 – 2024-06-3024116000 USD20250813Open filing evidence
2024-01-01 – 2024-06-3024116000 USD20250813Open filing evidence
2023-01-01 – 2023-12-310 USD20250331Open filing evidence